Show Summaries | Hide Summaries
We currently have no Breaking News on this stock.
CEMI vs. ETF Alternatives
Chembio Diagnostics Inc develops, manufacture market & licenses rapid point of care diagnostic tests that detect infectious diseases. Itsproducts are rapid tests for the detection of HIV 1/2 antibodies, & for the detection of HIV & Syphilis antibodies.
Other News & PR